Anti-TNF biosimilar demonstrates comparable growth, clinical outcomes in children with IBD
May 8th 2023Clinical outcomes of lab values were not statistically different in changes from baseline to 12 months between children with inflammatory bowel disease initiated on the TNF originator or biosimilar.